KEGG   DRUG: Imipenem, cilastatin and relebactam
Entry
D11621            Mixture   Drug                                   

Name
Imipenem, cilastatin and relebactam;
Recarbrio (TN)
Product
Component
Imipenem [DR:D00206], Cilastatin sodium [DR:D02194], Relebactam [DR:D10726]
Remark
Product: D11621<US>
Efficacy
Antibacterial
  Disease
Uncomplicated urinary tract infection [DS:H01176]
Brite
USP drug classification [BR:br08302]
 Antibacterials
  Carbapenems
   Imipenem/ Cilastatin/ Relebactam
    D11621  Imipenem, cilastatin and relebactam
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D11621
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11621
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11621
Other DBs
PubChem: 405226488
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system